Notch1 is an effector of Akt and hypoxia in melanoma development
Barbara Bedogni(Stanford University), Marianne Broome Powell(Stanford University)
Cited by 207
Related Papers
Targeting Extracellular Matrix Remodeling Restores BRAF Inhibitor Sensitivity in BRAFi-resistant Melanoma
|Clinical Cancer Research|2020|44
Noncanonical Activation of Notch1 Protein by Membrane Type 1 Matrix Metalloproteinase (MT1-MMP) Controls Melanoma Cell Proliferation
|Journal of Biological Chemistry|2014|37
MT1-MMP-dependent ECM processing regulates laminB1 stability and mediates replication fork restart
|PLoS ONE|2021|12
Notch1 blockade by a novel, selective anti-Notch1 neutralizing antibody improves immunotherapy efficacy in melanoma by promoting an inflamed TME
|Journal of Experimental & Clinical Cancer Research|2024|4
Co-inhibition of Notch1 and ChK1 triggers genomic instability and melanoma cell death increasing the lifespan of mice bearing melanoma brain metastasis
|Journal of Experimental & Clinical Cancer Research|2025|2